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Abstract
Objective. Treatment-resistant muscle wasting is an increasingly recognized problem in idiopathic inflam-
matory myopathy (IIM). TNF-a is thought to induce muscle catabolism via activation of nuclear factor-
kappa B (NF-kB). Several genes share homology with the NF-kB family of proteins. This study investigated
the role of NF-kB-related genes in disease susceptibility in UK Caucasian IIM.
Methods. Data from 362 IIM cases [274 adults, 49 (14.0) years, 72% female; 88 juveniles, 6 (3.6) years,
73% female) were compared with 307 randomly selected Caucasian controls. DNA was genotyped for
63 single nucleotide polymorphisms (SNPs) from NF-kB-related genes. Data were stratified by IIM sub-
group/serotype.
Results. A significant allele association was observed in the overall IIM group vs controls for the IKBL-62T
allele (rs2071592, odds ratio 1.5, 95% CI 1.21, 1.89, corrected P= 0.0086), which strengthened
after stratification by anti-Jo-1 or -PM-Scl antibodies. Genotype analysis revealed an increase for the
AT genotype in cases under a dominant model. No other SNP was associated in the overall IIM group.
Strong pairwise linkage disequilibrium was noted between IKBL-62T, TNF-308A and HLA-B*08 (D0 = 1).
Using multivariate regression, the IKBL-62T IIM association was lost after adjustment for TNF-308A or
HLA-B*08.
Conclusion. An association was noted between IKBL-62T and IIM, with increased risk noted in anti-Jo-1-
and -PM-Scl antibody-positive patients. However, the IKBL-62T association is dependent on TNF-308A
and HLA-B*08, due to strong shared linkage disequilibrium between these alleles. After adjustment of the
8.1 HLA haplotype, NF-kB genes therefore do not independently confer susceptibility in IIM.
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Introduction
The idiopathic inflammatory myopathies (IIMs) represent a
group of autoimmune muscle diseases characterized by
muscle weakness, inflammatory muscle infiltrates in
muscle biopsy samples and electromyographic abnorm-
alities on neurophysiological testing. Although mortality
rates are reportedly low [1, 2], IIM patients can suffer con-
siderable disease-related morbidity or treatment-related
complications. Thus, patients may become significantly
disabled, with progressive weakness. Adults with IIM
may suffer irreversible muscle wasting despite treatment
and apparent resolution of inflammatory cell infiltrates [3].
Juvenile cases may additionally suffer specific complica-
tions including ongoing skin disease such as ulceration,
calcinosis and joint contractures.
The cause of this irreversible muscle atrophy in adult IIM
is unknown, although it is speculated that disease-related
alteration of the endoplasmic reticulum stress response
may cause metabolic changes to energy metabolism
and fibre dysfunction [4]. The pro-inflammatory cytokine,
TNF-a, is involved in muscle protein catabolic processes.
TNF-a is thought to induce protein loss via oxidative acti-
vation of the myogenic transcription factor nuclear
factor-kappa B (NF-kB). Furthermore, NF-kB p50 and
p65 have been described within the inflammatory exud-
ates of different IIM subtypes [5]. Several genes have
been identified that share homology with the NF-kB
family of proteins, including NFKB1, NFKB1A, NFKB1B,
NFKB1E, IKBL (NFKBIL1), REL, RELB and BCL3. Current
evidence for genetic risk in IIM arises from candidate gene
studies comparing cases with controls. In a manner simi-
lar to other autoimmune diseases, the main IIM genetic
risk factors lie within the HLA region, notably with compo-
nents of the 8.1 common ancestral haplotype (8.1 haplo-
type) (HLA-B*08/DRB1*03/DQB1*02/DQA1*05) especially
in the presence of certain myositis-specific/associated
antibodies (MSAs/MAAs) [610]. Non-HLA genes are in-
creasingly recognized as conferring a degree of risk [11].
In view of the apparently key role that NF-kB may play in
skeletal muscle protein catabolism and the described clin-
ical problem of muscle dysfunction and wasting in IIM, the
study reported here investigated genes involved with the
NF-kB pathway in adult and juvenile UK Caucasian IIM
patients.
Patients and methods
Subjects
DNA was available from 362 UK Caucasian IIM cases.
Adult IIM patients (n= 274), aged 518 years of age at
disease onset, were recruited through the UK Adult
Onset Myositis Immunogenetic Collaboration (AOMIC)
[10]. JDM patients (n= 88) were recruited via the UK
Juvenile Dermatomyositis National (UK and Ireland)
Cohort Biomarker Study and Repository [1214].
Patients with PM, DM or JDM had probable or definite
myositis, based on the Bohan and Peter criteria [15, 16].
Myositis/CTD-overlap patients were included if they
fulfilled all of the following: (i) met published criteria for
their primary CTD [1721] or MCTD [22]; (ii) possessed
at least two of four Bohan and Peter criteria (proximal
muscle weakness, elevated muscle enzymes, character-
istic myopathic EMG changes and diagnostic muscle
biopsy); and (iii) possessed at least one MSA/MAA. A
standardized clinical data collection form detailed demo-
graphics and individual clinical details.
Controls
Three hundred and seven UK Caucasian control subjects
were recruited from blood donors and general practition-
er registers as described [10]. The study was approved
by local research ethics committees [Northern and
Yorkshire Multi-centre Research Ethics Committee (ju-
venile cases MREC 1/3/22); North West Research
Multi-centre Research Ethics Committee (adult cases
MREC 98/8/86)] and full informed consent was obtained
according to the Declaration of Helsinki.
Autoantibody typing
Serum was obtained from patients for determination of
MSAs: anti-synthetases: -Jo-1, -PL-7, -PL-12, -EJ, -OJ,
-KS; anti-Mi-2, anti-SRP, anti-155/140; and MAAs:
anti-PM-Scl, anti-Ku, anti-U1-RNP, anti-U3-RNP using
radioimmunoprecipitation, as previously described in
adult [10, 23] and juvenile IIM [13].
Genotyping
DNA samples were extracted from a peripheral blood
sample obtained from both cases and controls using a
standard phenolchloroform method. Single nucleotide
polymorphisms (SNPs) were genotyped using the
Sequenom MassArray iPLEX platform, as per the manu-
facturer’s instructions (http://www.sequenom.com/seq-
genotyping.html). HLA Class I and TNF typing have been
described previously [10, 24].
NF-kB SNPs
Sixty-three SNPs within the NF-kB family were initially se-
lected from the following genes: NFKB1, NFKB1A,
NFKB1B, NFKB1E, IKBL (NFKBIL1), REL, RELB and
BCL3. Thirty-eight haplotype tagging (ht) SNPs were se-
lected for genotyping using the Hapmap CEU population
(release 20, National Center for Biotechnology Information
B35 assembly, online at www.ncbi.nlm.nih.gov) by pair-
wise tagging, r2 cut-off50.8 and a minor allele frequency
(MAF) of 10%. The remainder of the SNPs were selected
on the basis of being synonymous, non-synonymous,
30-untranslated region or in the 50-upstream region.
Conserved non-coding SNPs were also selected using
an approach outlined by Bejerano et al. [25], to obtain
sequences of conserved non-coding regions from a
wide range of organisms, using the UCSC Genome
Browser database (http://genome.ucsc.edu/cgi-bin
/hgGateway). Fourteen SNPs were removed as they
were rejected by Sequenom assay design, three SNPs
were removed as they were not compatible with the
plexes created and three SNPs were rejected where the
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sample genotyping success rate was <85%. For the pur-
poses of analysis, assay success cut-off was set at 90%.
Thus, a remainder of 43 SNPs were available for the final
analysis (a summary of the SNPs is available in the sup-
plementary Table 1, available as supplementary data at
Rheumatology online). A power calculation was applied
to the SNP with the lowest MAF (rs4648127, 10%). For
95% power to detect an effect size of 2.0 at a 95% sig-
nificance level, a sample size of 338 cases and 282 con-
trols would be required.
Statistical analyses
Genotype frequencies for each NF-kB SNP were tested
for HardyWeinberg equilibrium (HWE) in each group.
Allele and genotype frequencies of these NF-kB SNPs
were compared between myositis cases and controls,
using Fisher’s exact test or chi-square test, as appropri-
ate. Where significant, data were expressed as odds
ratios (ORs) with exact 95% CIs and pointwise P-values
were corrected using Bonferroni. Linkage disequilibrium
(LD) was calculated using the measure of D0. The analyses
were also repeated after stratification by clinical and sero-
logical subgroup. Unless otherwise stated, the statistical
package Stata (release 9.2, Stata Corp., College Station,
TX, USA) was used to perform statistical analysis.
Results
The breakdown of the IIM groups was as follows: 274
adults, 49 (14.0) years, 72% female; 88 juvenile,
6 (3.6) years, 73% female. All 43 SNPs conformed to
HWE. The frequency of the IKBL-62T allele (rs2071592)
was significantly increased in the overall IIM group vs con-
trols (Table 1). This association persisted after stratifica-
tion by clinical subgroup, and no significant difference
was observed between the subgroup frequencies of
IKBL-62T. The data were then further stratified by sero-
logical subgroup. The IKBL-62T association was strength-
ened after stratification by either anti-Jo-1 or -PM-Scl
antibody (Table 1). Genotype analysis of the overall IIM
group revealed an increase of the AT genotype in cases
(Table 2), with a significant association noted under a
dominant model of inheritance (Table 3). No other SNP
was significantly increased in the overall IIM group or clin-
ical/serological subgroups. The relationship between
IKBL-62T, TNF-a and HLA Class I was then examined.
The relationship between TNF-308A and HLA-B*08 in
adult IIM has previously been described [24]. Strong pair-
wise LD was noted between IKBL-62T, TNF-308A and
HLA-B*08 (D0 = 1). Using multivariate logistic regression,
the IKBL-62T association with IIM was lost after adjusting
for the presence of either TNF-308A or HLA-B*08.
Discussion
This candidate gene study tested the hypothesis that
NF-kB-related genes may confer susceptibility in IIM.
An SNP, rs2071592 (IKBL-62T), was found to be
TABLE 1 IKBL-62T allele associations in clinical and antibody IIM subgroups
n
Minor allele (T)
frequency (%) OR (95% CI) P-value
Bonferroni-corrected
P-value
Controls 307 34.4
Overall 362 44.3 1.5 (1.21, 1.89) 0.0002 0.0086
PM 112 44.6 1.5 (1.12, 2.10) 0.004 0.17
DM 98 42.9 1.4 (1.03, 1.99 0.03 1.29
CTD/overlap 64 47.7 1.7 (1.18, 2.55) 0.006 0.26
JDM 88 42.6 1.4 (1.01, 2.0) 0.05 2.15
Jo-1 50 58.0 2.6 (1.72, 4.05) 0.00001 0.0004
PM-Scl 36 59.7 2.8 (1.72, 4.65) 0.00005 0.002
Significant antibody associations are shown in bold. Associations are presented assuming a dominant mode of inheritance.
TABLE 3 IKBL62 SNP genotype associations in overall IIM
cases vs controls
Genotype test P OR (95% CI)
AT + TT vs AA 0.00002 2.0 (1.45, 2.76)
TT vs AT + AA 0.15 1.38 (0.89, 2.14)
TT vs AA 0.003 2.06 (1.27, 3.34)
AT vs AA 0.88 0.96 (0.61, 1.53)
P-values are uncorrected.
TABLE 2 IKBL62 SNP genotype frequencies in combined
IIM cases compared with controls
Genotype Controls (n= 307) IIM (n= 362)
n (%) n (%)
AA 134 (43.6) 101 (27.9)
AT 135 (44.0) 202 (55.8)
TT 38 (12.4) 59 (16.3)
796 www.rheumatology.oxfordjournals.org
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significantly increased in IIM, especially in anti-Jo-1- and
PM-Scl-positive cases when compared with controls.
However, a strong LD relationship was confirmed be-
tween IKBL-62T and alleles forming part of the HLA 8.1
ancestral haplotype, and indeed after adjusting for TNF-
308A and HLA-B*08, the association of IKBL-62T with IIM
was lost.
The IKBL-62T SNP implicated in this study is in the pro-
moter region of the IKBL gene, which is located on the
telomeric end of the MHC on Chromosome 6, and codes
for a member of the IkB family. IkB proteins have a regu-
latory role, through binding and then sequestration of
NF-kB in the cytoplasm, thus inhibiting translocation to
the nucleus [26]. Polymorphisms within genes encoding
IkB proteins have been investigated in a number of
other autoimmune conditions including multiple sclerosis,
RA, type 1 diabetes mellitus, SLE and Grave’s disease in
different populations [2733].
Data surrounding the IKBL-62T SNP remain conflicting.
Disruption of an E-box binding element in the IKBL pro-
moter by the IKBL-62T SNP has been described in bind-
ing studies [34], which of interest is a sequence shared in
many B- and T-cell lineage-specific genes. Decreased
IKBL promoter activity has also been functionally asso-
ciated with the IKBL-62A allele, culminating in an exag-
gerated NF-kB-mediated inflammatory response [35].
A study of subjects with Grave’s disease identified
a higher frequency of IKBL-62A when compared with
healthy controls [33]. In contrast, IKBL-62T was found to
be linked to RA in a Japanese population study [29], then
known as SNP96452 (OR 2.08, P= 0.0088). This study did
not, however, report on LD effects with HLA-DRB1 alleles,
nor was the effect replicated in a UK family-based study
[30] or a Spanish casecontrol study [31].
There is increasing evidence for a role of the NF-kB in
alteration of normal muscle physiology. Transgenic over-
expression of NF-kB (via activated IKB kinase b) causes
profound muscle wasting in mice via accelerated protein
breakdown through ubiquitin-dependent proteolysis [36].
In a mechanistically reverse experiment, Mourkioti et al.
[37] demonstrated that suppression of NF-kB response by
IKK2 muscle-specific deletion protected skeletal muscle
from atrophy despite denervation injury via both enhanced
regeneration (satellite cell activation) and reduced fibrosis.
In human IIM, NF-kB activation has been demonstrated
by western blot analysis and electrophoretic mobility shift
assays on muscle biopsies in patients with PM and DM
[38]. Furthermore, NF-kB p50 and p65 is found in CD4+ T
cells in muscle biopsies from both PM and IBM [5]. In
human IBM and a myositis mouse model, overexpression
of MHC Class I on muscle fibres results in activation of
NF-kB and an endoplasmic reticulum stress response
[4, 39, 40]. LEF, among its many actions, is a potent
NF-kB inhibitor and has been reported to be effective in
resistant cases of PM and DM [41, 42].
Alleles forming part of the 8.1 Caucasian MHC com-
mon ancestral haplotype (HLA-A1-B8-Cw7-DRB1*0301-
DQA1*0501-C4A*Q0) occur in strong LD within
Caucasian populations in northern and western Europe,
and represent risk factors for a large number of immuno-
pathological diseases [43]. To date, the 8.1 haplotype has
also been identified as a major risk factor in IIM [44, 45].
Thus, IKBL-62T confers risk for IIM as this allele forms part
of the 8.1 haplotype where it shares strong LD with other
alleles. We hypothesize that an altered NF-kB response
and cytokine profile could relate to previous observations
that the 8.1 haplotype confers an immune hyperrespon-
siveness [46, 47].
Due to the rarity of IIM, difficulties will always be
encountered when trying to recruit a sufficient number of
cases for analysis in genetic association studies that
examine SNPs with a modest effect size. The present
study was not powered to detect associations after strati-
fication by disease or serological subgroups. This may
also explain why no significant associations were
observed for the other SNPs with a low MAF. The SNPs
tested were htSNPs, which means that the true causal
SNP may not have been tested directly in the current
study. Due to the limited number of SNPs tested and
assay design failure, there will be incomplete coverage
of the tested regions. Furthermore, we have not corrobo-
rated our findings with functional data. Finally, clinical as-
sociations with these SNPs may be due to factors other
than irreversible muscle atrophy, certainly within the ju-
venile cohort where this clinical feature is generally not
typical.
To conclude, these findings describe the association of
IKBL-62T with IIM susceptibility in a large cohort of adult
and juvenile UK Caucasians. Significant differences are
not apparent between IIM subgroups and the risk appears
strongest in anti-Jo-1 and -PM-Scl cases, where the 8.1
haplotype association is the strongest. This study furthers
our understanding of the 8.1 haplotype in IIM and should
trigger off more detailed and functional studies into
NF-kB-related pathways.
Rheumatology key messages
. An association is noted between IKBL-62T and IIM,
and increased risk in Jo-1/PM-Scl-positive patients.
. The IKBL-62T association is dependent on TNF-
308A and HLA-B*08 due to strong shared LD.
. NF-kB genes do not confer susceptibility in IIM
after adjustment of the 8.1 HLA haplotype.
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